secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0000950170-24-071056
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar posts updated corporate presentation; no specific changes disclosed
---------------------------------------------------------------------------

- Company posted updated slide presentation on its website on June 10, 2024.
- Presentation will be used in meetings with investors and analysts.
- No financial results or material developments included in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000095017024071056/0000950170-24-071056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000095017024071056/lrmr-20240610.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-071056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer